跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
德巴金 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Sodium Valproate Sustained-release Tablets(Ⅰ)
Approved
化学药品
Sodium Valproate Sustained-release Tablets(Ⅰ)
SANOFI-AVENTIS FRANCE
🇨🇳 National Medical Products Administration
Approval Date
Jun 8, 2021
Approval ID
887BBgrNBkL
Company
SANOFI-AVENTIS FRANCE
Type
化学药品
Approval Details
Approval Id
887BBgrNBkL
Approval Number
国药准字HJ20171272
Generic Name
丙戊酸钠缓释片(Ⅰ)
Generic Name En
Sodium Valproate Sustained-release Tablets(Ⅰ)
Trade Name
德巴金
Drug Type
化学药品
Dosage Form
片剂
Strength
0.5g
Reg Date
2021-06-08
Expired Date
2026-06-07
Company Name
SANOFI-AVENTIS FRANCE
Production Company Name
SANOFI WINTHROP INDUSTRIE
Company Detail Path
/organization/sanofi-aventis-france
Production Company Detail Path
/organization/sanofi-winthrop-industrie
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jun 8, 2021
Approval ID
887BBgrNBkL
Type
化学药品
Back to NMPA Approvals
